New market for trying to stay young has popped up and it involves blood transfusions from young people to older ones.
Jesse Karmazin’s start-up, Ambrosia, is charging about $8,000 a pop for blood transfusions from people under 25, Karmazin said at Code Conference on Wednesday.
Ambrosia, which buys its blood from blood banks, now has about 100 paying customers. Anyone over 35 is eligible for its transfusions.
According to Vanity Fair, Karmazin was inspired to found Ambrosia after seeing studies researchers had done involving sewing mice together with their veins conjoined. Some aspects of aging, one 2013 study found, could be reversed when older mice get blood from younger ones, but other researchers haven’t been able to replicate these results, and the benefits of parabiosis in humans remains unclear. “I think the animal and retrospective data is compelling, and I want this treatment to be available to people,” Karmazin told the MIT Technology Review.
Though Karmazin emphasized at Code Conference that Ambrosia’s goal isn’t explicitly to cure or reverse aging in humans, he reports his customers see positive improvements related to heart disease, cancer, and Alzheimer’s disease, science outlet New Scientist reported Wednesday. “I don’t want to say the word panacea, but here’s something about teenagers,” Karmazin told New Scientist.
You can read the rest here at EconomicPolicyJournal.com